Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Shiseido Arbitration
View:
Post by Ingiboy on Aug 09, 2022 8:34pm

Shiseido Arbitration

We are 9 days away from 10 months with the Shiseido Arbitration.  I am dumbfounded that a simple dispute over did one, both or neither of these companies break the contract.  I am sure they have presented their individual cases long ago.  Why the wait?  Let's hope this does not go to Oct. 18th because that would be silly.
Comment by MetzGER on Aug 10, 2022 9:18am
This 2 months waiting wont kill us anymore. I am waiting For 4 Years so 2 months is No Problem For me
Comment by Genie29j on Aug 12, 2022 11:34pm
The amount of time this is taking with Shiseido - I feel is a good sign 1. If this was dead upon arrival, I think we would have heard by now 2. Replicel clearly is putting up a fight.  3. They are working out some sort of deal (let's hope it's a multi million dollar global buyout of RCH-01 rights and corresponding patents for $350M+, which would equate to approx $7-8 / share)
Comment by Ingiboy on Aug 13, 2022 9:54am
Are you speculating they might be working on a deal or have you heard somethng ?  One thing we forget about is Replicel I assume has patents surrounding RCH-01.  One way or another Shiseido has to honour those patents.  The cannot just receive the initial transfer of technology as per the contract then just move on saying they no longer  recognize the contract and continue to ...more  
Comment by Ingiboy on Aug 15, 2022 10:28am
This from Twitter Oct. 17th 2020: " RepliCel Life Sciences Inc. @RepliCel · Oct 17, 2020  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities